‘The man who saved the world’: is AstraZeneca’s boss worth his millions?
Pascal Soriot’s bonus might be deserved, but that doesn’t mean it’s necessarily wise
There can’t be many company bosses in Britain, or elsewhere in the world, “more deserving of a decent bonus this year than AstraZeneca’s Pascal Soriot”, said Ben Marlow in The Daily Telegraph. No other pharmaceutical giant pledged to produce a jab on a not-for-profit basis, and Astra’s AZD1222 has been “pivotal in turning the tide” against a disease that has infected 160 million and killed 3.3 million worldwide.
Yet, incredibly, the company’s plans to reward its French boss have encountered “a storm of protest” from shareholders aghast at plans to hike his pay package from £15.4m to a maximum of £17.8m. The “faceless” but influential Investment Association waded in with a so-called “amber-top” warning – its second highest level of alert. Institutional investors Aviva and Standard Life Aberdeen (soon to be rebranded as Abrdn) both voted against the proposals, along with 40% of other investors at this week’s AGM. So Soriot will get his bonus – but he gets an undeserved punch on the nose too.
“Seconds out. In the blue corner, the man who saved the world. In the red? A bunch of corporate governance box-tickers. Who would you want to win,” asked Alistair Osborne in The Times. In fairness, this row was “a bit more nuanced than that”. Astra has “naughtily flouted” a City rule that changes to pay policy must be “three-year, not annual” events. Moreover, bumping up Soriot’s potential bonus to 900% of his £1.33m salary is unheard of at a big FTSE 100 group, and “comes perilously close to the symbolic no-no of 1,000%”. Still, “rules are there to be broken”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It’s hard to argue that Soriot’s contribution isn’t worth £18m: his brave gamble on the Astra/Oxford jab “is the key reason for Britain’s faster Covid recovery”. What’s more, Astra shareholders have had £30bn of capital value since Soriot rejected Pfizer’s takeover bid in 2014. “Throwing big money at your top team might look insensitive” amid a painful pandemic, said Lee Wild of Interactive Investor on ii.co.uk – but too many executives get rewarded for failure. Pascal Soriot isn’t one of them.
Funnily enough, said Helen Thomas in the FT, “it turns out the system can’t really cope with paying for success either”. And there’s the rub, said Patrick Hosking in The Times. Executive pay is “like an arms race”, and Soriot’s 900% will set “a new benchmark” for good and poor performers alike. Astra investors had an unattractive choice between “disloyalty to a world-beating company”, and “opening the floodgates to more opportunistic, precedent-smashing, norm-flouting pay proposals”. A pity Soriot couldn’t “settle for a knighthood instead”.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Who actually needs life insurance?
The Explainer If you have kids or are worried about passing on debt, the added security may be worth it
By Becca Stanek, The Week US Published
-
Sexual wellness trends to know, from products and therapies to retreats and hotels
The Week Recommends Talking about pleasure and sexual health is becoming less taboo
By Theara Coleman, The Week US Published
-
Is the AI bubble deflating?
Today's Big Question Growing skepticism and high costs prompt reconsideration
By Joel Mathis, The Week US Published
-
Why are dollar stores a microcosm for America's shrinkflation problem?
Today's Big Question Recent reports have tapped dollar stores as the top offenders of shrinkflation — even beyond grocery stores
By Justin Klawans, The Week US Published
-
New austerity: can public services take any more cuts?
Today's Big Question Some government departments already 'in last chance saloon', say unions, as Conservative tax-cutting plans 'hang in the balance'
By The Week UK Published
-
Has life in Russia regressed since the Ukraine invasion?
Today's big question The 'war economy' has defied Western sanctions as ordinary citizens rally round the regime
By Elliott Goat, The Week UK Published
-
Can DEI survive an anti-woke backlash?
Today's Big Question Activists take aim at corporate diversity programs
By Joel Mathis, The Week US Published
-
How did America avoid a recession in 2023?
Today's Big Question A downturn was inevitable. Until it wasn't.
By Joel Mathis, The Week US Published
-
Will the UK economy bounce back in 2024?
Today's Big Question Fears of recession follow warning that the West is 'sleepwalking into economic catastrophe'
By Chas Newkey-Burden, The Week UK Published
-
What does a slowdown in payroll additions mean for the coming year?
Today's Big Question New private payrolls were well below expectations this November, according to one report
By Justin Klawans, The Week US Published
-
Would tax cuts benefit the UK economy?
Today's Big Question More money in people's pockets may help the Tories politically, but could harm efforts to keep inflation falling
By The Week UK Published